Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Regulus Therapeutics Inc. (RGLS) Receiveable Turnover data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-46.36M |
|
-- |
|
-- |
|
$50.04M |
|
$-50.04M |
|
$3.68M |
|
$-46.36M |
|
$-46.36M |
|
$-46.36M |
|
$-46.36M |
|
$-46.36M |
|
$-46.36M |
|
$-50.04M |
|
$-51.25M |
|
56.35M |
|
56.35M |
|
$-0.82 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$82.34M |
|
$0.94M |
|
$1.84M |
|
$84.18M |
|
$7.50M |
|
-- |
|
$0.27M |
|
$7.77M |
|
$76.40M |
|
$76.38M |
|
$76.41M |
|
65.50M |
|
| Cash Flow Statement Financials | |
$-41.67M |
|
$-35.98M |
|
$92.42M |
|
$23.83M |
|
$38.59M |
|
$14.76M |
|
$7.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-60.68% |
|
-60.69% |
|
-55.07% |
|
-60.67% |
|
$1.17 |
|
$-0.75 |
|
$-0.74 |
|